Brief Statement for U.S. Consumers

Brief Statement for US Consumers

PL-19701-00
Issue date: March, 2018

IMPORTANT SAFETY INFORMATION FOR PROMETRA DRUG DELIVERY SYSTEMS - BRIEF STATEMENT

Indications: The Prometra II Programmable Pump is indicated for intrathecal infusion of Infumorph® (preservative free morphine sulfate sterile solution) or preservative-free sterile 0.9% saline solution (Sodium Chloride Injection, USP).
Drug Information: See Infumorph® labeling for indications, contraindications, warnings, precautions, adverse reactions and under/over dose symptoms. Tell your doctor about any drug related signs or symptoms you may experience.

Contraindications: The Prometra pump system should not be implanted if: you have an infection; your body type cannot safely accommodate the pump size and weight; the pump cannot be implanted 1 inch below the skin; you have allergies to catheter or pump materials; you have had an intolerance to implanted devices in the past; your spinal column anatomy obstructs cerebrospinal fluid flow or prevents intrathecal drug delivery; you are deemed an unsuitable candidate after psychological evaluation; you have an occupation with exposure to high current industrial equipment, powerful magnets or transmitting towers; you require hyperbaric therapy.

Warnings: FAILURE TO EMPTY THE PUMP PRIOR TO EXPOSURE TO MRI ENVIRONMENT COULD RESULT IN DRUG OVERDOSE THAT COULD LEAD TO SERIOUS PATIENT INJURY OR DEATH; USE OF UNAPPROVED DRUGS (e.g., DRUG COCKTAILS, PHARMACY COMPOUNDED DRUGS, MORPHINE WITH PRESERVATIVES, ETC.) WITH THE PROMETRA II PUMP COULD RESULT IN PUMP FAILURE AND/OR SERIOUS ADVERSE EVENTS INCLUDING DEATH. If an MRI is required, your doctor MUST empty your pump of all medication prior to the MRI.

Precautions: Tell your doctor about any new neurological signs or symptoms you may experience. Pain on injection may be early sign of infection. Safety and effectiveness for use in pediatric patients under 22 years old has not been investigated or established.

Adverse Events: Pocket seroma/hematoma with or without infection, pump site skin erosion, pump rotation/migration/flipping or twisting, adverse reaction to pump materials, granuloma; infection in intrathecal space, including meningitis, nerve damage. Additional potential adverse events are included in the Patient Guide.

For full disclosure of contraindications, warnings, precautions, adverse events and MRI Instructions, please call Flowonix at 855-356-9665 and/or consult Flowonix website at Flowonix.com

Caution: Federal Law (USA) restricts this device to sale by or on the order of a physician.